Fungal Infections Complicating COVID-19
Hoenigl, Martin
Fungal Infections Complicating COVID-19 - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 - 1 electronic resource (98 p.)
Open Access
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions. Although the majority of cases have asymptomatic or mild infections, a significant proportion of cases progress to severe pneumonia and acute respiratory distress syndrome requiring critical care. Opportunistic infections following severe respiratory viral infections have been recognized since the 1918 influenza pandemic. Among critically ill patients with COVID-19, secondary fungal infections caused by Aspergillus and Candida spp. are increasingly described, affecting up to 30% of COVID-19 patients requiring intensive care treatment. This collection of manuscripts focuses on fungal infections complicating COVID-19, including immunological mechanisms and pathogenesis, diagnosis, and treatment.
Creative Commons
English
books978-3-0365-0555-8 9783036505541 9783036505558
10.3390/books978-3-0365-0555-8 doi
Medicine
SARS-CoV-2 co-infection pulmonary aspergillosis ICU azole-resistant Aspergillus Aspergillus fumigatus CAPA TR34L98H SARS COV-2 Aspergillus novel coronavirus superinfection risk factors prevalence challenges immune response expert statement European Confederation of Medical Mycology COVID-19 fungaemia Saccharomyces co-infections invasive aspergillosis putative probable Sars-CoV-2 PCR galactomannan classification COVID-19 pneumonia invasive pulmonary aspergillosis diagnosis multi-triazole resistance COVID-19 associated invasive pulmonary aspergillosis coinfection diabetes bloodstream infection Candida glabrata echinocandin resistance FKS mutation candidemia candiduria oral candidiasis mycobiome n/a
Fungal Infections Complicating COVID-19 - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 - 1 electronic resource (98 p.)
Open Access
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions. Although the majority of cases have asymptomatic or mild infections, a significant proportion of cases progress to severe pneumonia and acute respiratory distress syndrome requiring critical care. Opportunistic infections following severe respiratory viral infections have been recognized since the 1918 influenza pandemic. Among critically ill patients with COVID-19, secondary fungal infections caused by Aspergillus and Candida spp. are increasingly described, affecting up to 30% of COVID-19 patients requiring intensive care treatment. This collection of manuscripts focuses on fungal infections complicating COVID-19, including immunological mechanisms and pathogenesis, diagnosis, and treatment.
Creative Commons
English
books978-3-0365-0555-8 9783036505541 9783036505558
10.3390/books978-3-0365-0555-8 doi
Medicine
SARS-CoV-2 co-infection pulmonary aspergillosis ICU azole-resistant Aspergillus Aspergillus fumigatus CAPA TR34L98H SARS COV-2 Aspergillus novel coronavirus superinfection risk factors prevalence challenges immune response expert statement European Confederation of Medical Mycology COVID-19 fungaemia Saccharomyces co-infections invasive aspergillosis putative probable Sars-CoV-2 PCR galactomannan classification COVID-19 pneumonia invasive pulmonary aspergillosis diagnosis multi-triazole resistance COVID-19 associated invasive pulmonary aspergillosis coinfection diabetes bloodstream infection Candida glabrata echinocandin resistance FKS mutation candidemia candiduria oral candidiasis mycobiome n/a